Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Neuroimmunol ; 370: 577933, 2022 09 15.
Article in English | MEDLINE | ID: covidwho-1983506

ABSTRACT

This case series describes 9 patients diagnosed with myelin oligodendrocyte glycoprotein (MOG)-IgG associated disorder (MOGAD) following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Patients developed neurological symptoms between 4 days and 5 weeks following SARS-CoV-2 infection. Myelitis was observed in 4 patients; 4 presented with optic neuritis; and encephalopathy was observed in 3. Serum MOG-IgG cell-based assay was medium or high positive in each case. The majority of patients had near-complete recovery following acute immunosuppression. This series adds to the growing number of cases of central nervous system demyelination following SARS-CoV-2 infection and highlights a potential role of infection in the immunopathogenesis of MOGAD.


Subject(s)
COVID-19 , Neuromyelitis Optica , Autoantibodies , COVID-19/complications , Humans , Immunoglobulin G , Myelin-Oligodendrocyte Glycoprotein , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL